Savara Inc (SVRA) stock
SVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.48+0.02 (+0.34%)
Close on Nov 17, 2026Market cap $920.46MP/E –Yield –
Savara cash
Cash and short-term investments held at the end of each period.
Savara's cash was $173.03M at Jun 30, 2026. For fiscal 2025 it was $235.70M, up 20.1% from the year before. Over ten years it grew 19.1% a year on average. The highest annual figure on record is $235.70M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $235.70M | +20.1% |
| FY2024 | Dec 31, 2024 | $196.33M | +21.0% |
| FY2023 | Dec 31, 2023 | $162.32M | +29.0% |
| FY2022 | Dec 31, 2022 | $125.88M | -21.9% |
| FY2021 | Dec 31, 2021 | $161.17M | +96.1% |
| FY2020 | Dec 31, 2020 | $82.19M | -32.5% |
| FY2019 | Dec 31, 2019 | $121.76M | +9.9% |
| FY2018 | Dec 31, 2018 | $110.83M | +17.5% |
| FY2017 | Dec 31, 2017 | $94.31M | +734.6% |
| FY2016 | Dec 31, 2016 | $11.30M | -72.4% |
| FY2015 | Dec 31, 2015 | $41.00M | +223.1% |
| FY2014 | Dec 31, 2014 | $12.69M | -50.6% |
| FY2013 | Dec 31, 2013 | $25.68M | -29.7% |
| FY2012 | Dec 31, 2012 | $36.51M | -28.0% |
| FY2011 | Dec 31, 2011 | $50.70M | +81.2% |
| FY2010 | Dec 31, 2010 | $27.98M | +222.8% |
| FY2009 | Dec 31, 2009 | $8.67M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $173.03M | +18.2% |
| Q1 FY2026 | Mar 31, 2026 | $202.77M | +17.5% |
| Q4 FY2025 | Dec 31, 2025 | $235.70M | +20.1% |
| Q3 FY2025 | Sep 30, 2025 | $124.39M | -43.3% |
| Q2 FY2025 | Jun 30, 2025 | $146.44M | +20.5% |
| Q1 FY2025 | Mar 31, 2025 | $172.50M | +20.6% |
| Q4 FY2024 | Dec 31, 2024 | $196.33M | +21.0% |
| Q3 FY2024 | Sep 30, 2024 | $219.44M | +30.4% |
| Q2 FY2024 | Jun 30, 2024 | $121.52M | +15.5% |
| Q1 FY2024 | Mar 31, 2024 | $143.04M | +24.6% |
| Q4 FY2023 | Dec 31, 2023 | $162.32M | +29.0% |
| Q3 FY2023 | Sep 30, 2023 | $168.25M | +25.5% |
| Q2 FY2023 | Jun 30, 2023 | $105.18M | -26.2% |
| Q1 FY2023 | Mar 31, 2023 | $114.78M | -24.4% |
| Q4 FY2022 | Dec 31, 2022 | $125.88M | -21.9% |
| Q3 FY2022 | Sep 30, 2022 | $134.08M | -21.5% |
| Q2 FY2022 | Jun 30, 2022 | $142.44M | -21.2% |
| Q1 FY2022 | Mar 31, 2022 | $151.80M | -21.2% |
| Q4 FY2021 | Dec 31, 2021 | $161.17M | +96.1% |
| Q3 FY2021 | Sep 30, 2021 | $170.81M | +81.1% |
| Q2 FY2021 | Jun 30, 2021 | $180.67M | +81.4% |
| Q1 FY2021 | Mar 31, 2021 | $192.71M | +83.6% |
| Q4 FY2020 | Dec 31, 2020 | $82.19M | -32.5% |
| Q3 FY2020 | Sep 30, 2020 | $94.34M | -11.2% |
| Q2 FY2020 | Jun 30, 2020 | $99.61M | -10.9% |
| Q1 FY2020 | Mar 31, 2020 | $104.99M | -0.2% |
| Q4 FY2019 | Dec 31, 2019 | $121.76M | +9.9% |
| Q3 FY2019 | Sep 30, 2019 | $106.28M | -5.1% |
| Q2 FY2019 | Jun 30, 2019 | $111.73M | +49.5% |
| Q1 FY2019 | Mar 31, 2019 | $105.18M | +23.8% |
| Q4 FY2018 | Dec 31, 2018 | $110.83M | +17.5% |
| Q3 FY2018 | Sep 30, 2018 | $112.05M | +110.3% |
| Q2 FY2018 | Jun 30, 2018 | $74.76M | +22.3% |
| Q1 FY2018 | Mar 31, 2018 | $84.98M | +989.5% |
| Q4 FY2017 | Dec 31, 2017 | $94.31M | +734.6% |
| Q3 FY2017 | Sep 30, 2017 | $53.29M | +97.4% |
| Q2 FY2017 | Jun 30, 2017 | $61.13M | – |
| Q1 FY2017 | Mar 31, 2017 | $7.80M | – |
| Q4 FY2016 | Dec 31, 2016 | $11.30M | – |
| Q3 FY2016 | Sep 30, 2016 | $27.00M | – |
See a number that looks wrong?